3YAMAMOTO H, KUNO Y, SUGIMOTO S, et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions [ J]. J Control Release,2005,102 (2) :373 - 381.
4LU Bin, XIONG Su-bin, YANG Hong, et al. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases I: Formulation and in vitro characterization [ J ]. Int J Pharm,2006,307 (2) : 168 - 174.
5YIN Ya-shu, CHEN Da-wei, QIAO Ming-xi, et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin [ J ]. J Control Release,2006,116 ( 3 ) :337 - 345.
6BROWN D M, WILSON M R, MACNEE W, et al. Sizedependent proinflamrnatory effects of ultrafine polystyrene particles : a role for surface area and oxidative stress in the enhanced activity of ultrafines [J]. Toxicol Appl Pharmacol,2001,175 ( 3 ) : 191 - 199.
7OBERDORSTER G, SHARP Z, ATUDOREI V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats [ J ]. J Toxicol Environ Health A, 2002,65 ( 20 ) : 1531 - 1543.
8LOCKMAN P R, OYEWUMI M O, KOZIARA J M, et al. Brain uptake of thiamine-coated nanoparticles [ J ]. J Control Release,2003,93 (3) :271 -282.
9OBERDORSTER G, SHARP Z, ATUDOREI V, et al. Translocation of inhaled ultra_fine particles to the brain [J]. Inhalation Toxicology,2004, 16(6 - 7) :437 - 445.
10CHOW S, CHO M J, JEONG J Y, et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles [J]. Toxicology and Applied Pharmacology,2010, 245(1 ) :116 - 123.
